Topics
A to Z
Data &
 Statistics
Forms &
Publications
News &
Advisories
Licensing &
Certification
Rules &
Regulations
Public Health
Directory

Parvovirus (Human) B19 Antibodies, IgG and IgM

Updated

12/2/2016

Other Names Erythema Infectiosum; Fifth Disease
How to Order
Check the Parvovirus box on the Virology/Immunology request (form 42)
Availability
All clients
Methodology
Enzyme Immunoassay (EIA)
Performed
Once per week, dependent upon specimen volume
Time to Reporting
1 to 7 working days after receipt of specimen.
CPT Code
86747 x 2


Specimen Collection Details

Collection
One 7 ml red top tube or serum separator tube (SST). Plasma is also an acceptable specimen type.
Optimal Volume
Blood: 5 ml; Serum or plasma 1-2 ml
Minimum Volume
Blood: 3 ml; Serum or plasma 1 ml
Handling
After blood clots, keep specimen refrigerated until transport. DO NOT FREEZE. If possible remove the serum from the clot as soon as possible.
Transport
Transport at refrigerated temperatures (2-8° C) for receipt at the OSPHL within 5 calendar days.
Rejection Criteria
Contaminated, lipemic, icteric, or grossly hemolyzed specimens and specimens unable to be tested within 7 calendar days of specimen collection will be rejected.
 
Specimens are subject to the requirements of the OSPHL Specimen Submission Policy and Criteria, available at: http://bit.ly/SpecimenCriteria.
Comments
This test is used for serological determination of past, recent or current infection with Parvovirus B19. It is also used for testing women of childbearing age to determine serological status where there is a suspicion of exposure to Parvovirus B19. Additionally, the assay may also be used in the diagnosis of fifth disease (erythema infectiosum).